Company / Shareholders' Equity
ATOSSA THERAPEUTICS, INC. Shareholders' Equity History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$9.5M
FY2016
5-year range
$54.0K / $10.6M
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $11M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2016 with a 3-year CAGR of +460.3%.
Declined from $11M to $9M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +460.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +460.3%, indicating consistent growth.
- In FY2016, shareholders' equity increased 0.0% year-over-year.
- Peak shareholders' equity was recorded in FY2014.
- Lowest shareholders' equity in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $9.5M | +0.0% |
| FY2015 | $9.5M | -10.4% |
| FY2014 | $10.6M | +19532.7% |
| FY2013 | $54.0K | +0.0% |
| FY2012 | $54.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026